Volume 30, Issue 21 (February 15, 2022)
For more information, click HERE.
PFAS Testing: LC/MS/MS and Other Techniques Take on the Challenge
SLAS2022 Chooses a Hybrid Format
The latest on Illumina’s EU dispute, Bruker’s LC investments and changes at Fluidigm, plus much more…
Fourth Quarter Results: Bio-Rad Laboratories, Bio-Techne, Biotage and QIAGEN
Biopharma and Government
< Previous Article | Next Article >